Robarts Clinical Trials

3.0k papers and 129.8k indexed citations i.

About

In recent decades, authors affiliated with Robarts Clinical Trials have published 3.0k papers, which have received a total of 129.8k indexed citations. Scholars at this organization have produced 642 papers in Radiology, Nuclear Medicine and Imaging, 604 papers in Surgery and 531 papers in Genetics on the topics of Inflammatory Bowel Disease (376 papers), Advanced MRI Techniques and Applications (293 papers) and Microscopic Colitis (250 papers). Their work is cited by papers focused on Epidemiology (23.3k citations), Genetics (22.4k citations) and Surgery (20.7k citations). Authors at Robarts Clinical Trials collaborate with scholars in Canada, United States and United Kingdom and have published in prestigious journals including Nature, Science and New England Journal of Medicine. Some of Robarts Clinical Trials's most productive authors include Guangyong Zou, Robert A. Hegele, Brian G. Feagan, Ravi S. Menon, Michael Eliasziw, Aaron Fenster, Brian K. Rutt, Allan Donner, John K MacDonald and Stefan Everling.

In The Last Decade

Fields of papers published by authors at Robarts Clinical Trials

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Robarts Clinical Trials at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Robarts Clinical Trials at the time of their publication.

Countries citing scholars working at Robarts Clinical Trials

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Robarts Clinical Trials. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Robarts Clinical Trials with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robarts Clinical Trials more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025